SCHEMBL5203748

SCHEMBL5203748

O=C(O)c1ccc(-c2ccc(-c3ccc(C(F)(F)F)cc3)o2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 3/20 0.62
RXRA P19793 1/20 0.57
RXRB P28702 1/20 0.57
RXRG P48443 1/20 0.57
CYP2C8 P10632 1/20 0.56
KDM4E B2RXH2 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
EPHX2 P34913 1/20 0.50
MAP4K4 O95819 1/20 0.49
NQO2 P16083 3/20 0.49
PPARD Q03181 1/20 0.47
MAPK1 P28482 2/20 0.47
MAP2K4 P45985 2/20 0.47
MAPK6 Q16659 2/20 0.47
MAPKAPK3 Q16644 1/20 0.47
MAPKAPK5 Q8IW41 1/20 0.47
SLC6A2 P23975 1/20 0.46
P2RY14 Q15391 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505133 0.85 SRD5A2 (0.77) SRD5A2RXRARXRBRXRGCYP2C8
SCHEMBL5963142 0.85 TDP1 (0.69) SRD5A2KDM4ETDP1NQO2KEAP1
SCHEMBL5206010 0.85 NQO2 (0.51) TDP1CES2CES1NQO2MAP2K4
SCHEMBL5209176 0.85 KDM4E (0.56) SRD5A2RXRARXRBRXRGKDM4E
Hydrochloric Acid SCHEMBL5313295 0.83 SRD5A2 (0.74) SRD5A2RXRARXRBRXRGCYP2C8
SCHEMBL78879 0.83 SRD5A2 (0.87) SRD5A2RXRARXRBRXRGCYP2C8
SCHEMBL1330891 0.83 SRD5A2 (0.87) SRD5A2RXRARXRBRXRGCYP2C8
SCHEMBL3744237 0.83 ALDH1A1 (0.64) SRD5A2KDM4E
Hydrochloric Acid SCHEMBL10434191 0.81 ALDH1A1 (0.62) SRD5A2KDM4E
SCHEMBL3417241 0.81 ALDH1A1 (0.67) SRD5A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223791-B2 Function regulator for retinoid relative receptor TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-05-29 US disclosed
US-20040157881-A1 Function regulator for retinoid relative receptor TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
EP-1405636-A1 FUNCTION REGULATOR FOR RETINOID RELATIVE RECEPTOR Takeda Chemical Industries, Ltd. (JP) 2004-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157881-A1 Function regulator for retinoid relative receptor RXRA, RARA, RARG SRD5A2 323/4885RXRA 1/4885RXRB 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.